| Literature DB >> 23424347 |
Abstract
Clinical decision making stands to benefit from ultrasensitive molecular diagnostic tools that identify disease-related changes in biomarker levels before advanced clinical signs and symptoms manifest.Year: 2006 PMID: 23424347 PMCID: PMC3571029
Source DB: PubMed Journal: Biotechnol Healthc ISSN: 1554-169X